BNP Paribas Aktienanleihe SNW 30..../ DE000PC7FQZ5 /
2024-05-13 9:20:27 AM | Chg.+0.05 | Bid10:27:40 AM | Ask10:27:40 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.80EUR | +0.05% | 100.81 Bid Size: 100,000 |
100.91 Ask Size: 100,000 |
SANOFI SA INHABER ... | 80.00 EUR | 2024-12-30 | Call |
GlobeNewswire
7:00 AM
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
05-10
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVI...
GlobeNewswire
05-08
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-07
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
05-02
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
04-25
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
GlobeNewswire
04-23
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
GlobeNewswire
04-17
Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in ...
GlobeNewswire
04-10
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Upda...